Palavra-chave: CHRONIC MYELOID LEUKAEMIA

BCR-ABL GENE RUNX1 GSTT1 CML SARS-COV-2 SECOND-GENERATION S-TRANSFERASE MU1 RESPONSE TO SECOND-LINE GENERIC IMATINIB ANGIOGENESIS INHIBITOR BCR-ABL1 IMATINIB VACCINES HOCT1 POLYMORPHISMS D-HPLC DASATINIB CYTOGENETIC RESPONSES PERIPHERAL-BLOOD NILOTINIB TYROSINE KINASE INHIBITORS GSTM1 EXON 6 PHILADELPHIA CHROMOSOME-POSITIVE THETA1